SCHEMBL4448803

SCHEMBL4448803

CC(C)(C)Pc1ccc2ccccc2c1-c1cccc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.40
DNMT1 P26358 1/20 0.39
PPARG P37231 3/20 0.38
PPARA Q07869 3/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
PPARD Q03181 1/20 0.38
ALDH1A1 P00352 5/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TYMP P19971 1/20 0.36
CYP2A6 P11509 2/20 0.35
TSHR P16473 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
GSK3B P49841 1/20 0.35
ADK P55263 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30831131 0.90 DNMT1 (0.39) DHFRDNMT1CYP2C9CYP2C19ALDH1A1
SCHEMBL12903863 0.81 DHFR (0.46) DHFRDNMT1ALDH1A1MAPTRAB9A
SCHEMBL7069207 0.77 DNMT1 (0.42) DHFRDNMT1ALDH1A1MAPTRAB9A
SCHEMBL18922438 0.74 GSK3B (0.36) DHFRDNMT1PPARGPPARACYP2C9
SCHEMBL10434031 0.74 ALDH1A1 (0.44) DHFRDNMT1CYP2C9CYP2C19ALDH1A1
SCHEMBL10434030 0.73 DHFR (0.40) DHFRDNMT1ALDH1A1MAPTRAB9A
SCHEMBL1095987 0.72 ALDH1A1 (0.43) DHFRPPARGPPARACYP2C9CYP2C19
SCHEMBL30122801 0.72 DNMT1 (0.47) DHFRDNMT1ALDH1A1MAPTRAB9A
SCHEMBL1933357 0.72 TLR8 (0.38) DHFRDNMT1ALDH1A1MAPTRAB9A
SCHEMBL9756475 0.71 DNMT1 (0.46) DHFRDNMT1ALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2012779-A2 PROCESS FOR THE PREPARATION OF INDAZOLYL UREAS THAT INHIBIT VANILLOID SUBTYPE 1 (VR1) RECEPTORS Abbott Laboratories (US) 2009-01-14 EP claimed
WO-2007121339-A2 PROCESS FOR THE PREPARATION OF INDAZOLYL UREAS THAT INHIBIT VANILLOID SUBTYPE 1 (VR1) RECEPTORS ABBOTT LABORATORIES (US) 2007-10-25 WO claimed